News MorphoSys AG

Equities

MOR

DE0006632003

Market Closed - Xetra Other stock markets 11:35:06 2024-05-07 am EDT			After market 03:59:41 pm
66.8 ^EUR	-0.15%		66.78	-0.04%

May. 06	MORPHOSYS : UBS reiterates its Neutral rating	ZD
Apr. 30	European Equities Traded in the US as American Depositary Receipts Decline	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

MorphoSys AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	10:01am	EQ
MorphoSys AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	May. 06	EQ
MorphoSys AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	May. 06	EQ
MORPHOSYS : UBS reiterates its Neutral rating	May. 06	ZD
MorphoSys AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	May. 03	EQ
MorphoSys AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	May. 03	EQ
MorphoSys AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	May. 03	EQ
MorphoSys AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	May. 03	EQ
MorphoSys AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	May. 02	EQ
MorphoSys AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	May. 02	EQ
MorphoSys AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	May. 02	EQ
MorphoSys AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	May. 02	EQ
European Equities Traded in the US as American Depositary Receipts Decline	Apr. 30	MT
MorphoSys AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	Apr. 30	EQ
MorphoSys AG Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 30	CI
MORPHOSYS : UBS remains Neutral	Apr. 30	ZD
Novartis target Morphosys multiplies losses - takeover schedule stands	Apr. 29	DP
MorphoSys : 1st Quarter Interim Statement 2024	Apr. 29	PU
MorphoSys AG Reports First Quarter 2024 Financial Results	Apr. 29	EQ
MorphoSys AG Reports First Quarter 2024 Financial Results	Apr. 29	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News MorphoSys AG

Equities

MOR

DE0006632003

Summary

Filters